| Characteristic | Percentage of respondents |
|---|---|
| Limiting how much drug companies can increase the price for prescription drugs each year to no more than the rate of inflation | 61% |
| Capping out-of-pocket costs for insulin at $35 a month | 59% |
| Placing a limit on out-of-pocket health care costs for seniors, such as co-pays for prescription drugs | 52% |
| Allowing the federal government to negotiate with drug companies to get a lower price on prescription drugs for people with Medicare | 48% |
| Expanding government health insurance coverage for lower-income people in states that have not expanded their Medicaid program | 42% |
| Increasing government funding for access to mental health services and training for mental health providers | 42% |
| Taking federal action to improve the safety and quality of care in nursing homes | 40% |
| Providing more funding to continue the COVID-19 pandemic response | 25% |
| Making permanent the additional financial help from the COVID-19 relief bill for people who buy their own insurance | 21% |
Download
Source
Source
Release date
March 2022
More information
Region
United States
Survey time period
March 15 to 22, 2022
Number of respondents
1,526 respondents
Age group
18 years and older
Method of interview
Computer-assisted telephone interviews (CATI)
Citation formats
